| Lipid polymer hybrid nanocarriers: Insights into synthesis aspects, characterization, release mechanisms, surface functionalization and potential implications S Shah, P Famta, RS Raghuvanshi, SB Singh, S Srivastava Colloid and Interface Science Communications 46, 100570, 2022 | 72 | 2022 |
| Exploring new Horizons in overcoming P-glycoprotein-mediated multidrug-resistant breast cancer via nanoscale drug delivery platforms P Famta, S Shah, E Chatterjee, H Singh, B Dey, SK Guru, SB Singh, ... Current Research in Pharmacology and Drug Discovery 2, 100054, 2021 | 46 | 2021 |
| Potential anti-epileptic phytoconstituents: An updated review J Kaur, P Famta, M Famta, M Mehta, S Satija, N Sharma, M Vyas, ... Journal of ethnopharmacology 268, 113565, 2021 | 40 | 2021 |
| Albumin-hitchhiking: fostering the pharmacokinetics and anticancer therapeutics P Famta, S Shah, N Jain, DA Srinivasarao, A Murthy, T Ahmed, ... Journal of Controlled Release 353, 166-185, 2023 | 37 | 2023 |
| Nanotechnology based drug delivery systems: Does shape really matter? S Shah, P Famta, D Bagasariya, K Charankumar, E Amulya, DK Khatri, ... International Journal of Pharmaceutics 625, 122101, 2022 | 33 | 2022 |
| Advancements in redox-sensitive micelles as nanotheranostics: a new horizon in cancer management A Sikder, G Vambhurkar, E Amulya, D Bagasariya, P Famta, S Shah, ... Journal of Controlled Release 349, 1009-1030, 2022 | 31 | 2022 |
| Quality by design (QbD) assisted Fabrication & evaluation of Simvastatin loaded Nano-Enabled thermogel for melanoma therapy P Famta, S Shah, V Fernandes, KC Kumar, D Bagasariya, KS Samim, ... International journal of pharmaceutics 628, 122270, 2022 | 28 | 2022 |
| Quality by design steered development of Niclosamide loaded liposomal thermogel for Melanoma: In vitro and Ex vivo evaluation S Shah, P Famta, V Fernandes, D Bagasariya, K Charankumar, DK Khatri, ... European Journal of Pharmaceutics and Biopharmaceutics 180, 119-136, 2022 | 27 | 2022 |
| Polymeric micelles loaded with glyburide and vanillic acid: I. Formulation development, in-vitro characterization and bioavailability studies J Kaur, M Gulati, P Famta, L Corrie, A Awasthi, S Saini, GL Khatik, ... International Journal of Pharmaceutics 624, 121987, 2022 | 27 | 2022 |
| Enigmatic role of exosomes in breast cancer progression and therapy P Famta, S Shah, DK Khatri, SK Guru, SB Singh, S Srivastava Life Sciences 289, 120210, 2022 | 26 | 2022 |
| Tumor-promoting aftermath post-chemotherapy: A focus on breast cancer P Famta, S Shah, N Jain, KC Kumar, D Bagasariya, DK Khatri, ... Life sciences 310, 121125, 2022 | 23 | 2022 |
| Tuning mesoporous silica nanoparticles in novel avenues of cancer therapy S Shah, P Famta, D Bagasariya, K Charankumar, A Sikder, R Kashikar, ... Molecular Pharmaceutics 19 (12), 4428-4452, 2022 | 22 | 2022 |
| Integration of miRNA’s theranostic potential with nanotechnology: promises and challenges for Parkinson’s disease therapeutics KP Tryphena, G Singh, N Jain, P Famta, S Srivastava, SB Singh, ... Mechanisms of Ageing and Development 211, 111800, 2023 | 20 | 2023 |
| Quality by design (QbD) abetted development of pioglitazone incorporated liposomes-loaded hyaluronic acid-based in situ hydrogel for the management of melanoma K Charankumar, D Bagasariya, N Jain, P Famta, S Shah, G Vambhurkar, ... Journal of Drug Delivery Science and Technology 84, 104453, 2023 | 19 | 2023 |
| Multifaceted applications of ulvan polysaccharides: Insights on biopharmaceutical avenues S Shah, P Famta, S Shahrukh, N Jain, G Vambhurkar, DA Srinivasarao, ... International Journal of Biological Macromolecules 234, 123669, 2023 | 19 | 2023 |
| Quality by design endorsed fabrication of Ibrutinib-loaded human serum albumin nanoparticles for the management of leukemia P Famta, S Shah, G Vambhurkar, DA Srinivasarao, N Jain, N Begum, ... European Journal of Pharmaceutics and Biopharmaceutics 190, 94-106, 2023 | 16 | 2023 |
| Biomimetic nanotherapeutics: Employing nanoghosts to fight melanoma D Bagasariya, K Charankumar, S Shah, P Famta, DK Khatri, ... European Journal of Pharmaceutics and Biopharmaceutics 177, 157-174, 2022 | 15 | 2022 |
| Immune cell–camouflaged surface-engineered nanotherapeutics for cancer management N Jain, S Shahrukh, P Famta, S Shah, G Vambhurkar, DK Khatri, ... Acta Biomaterialia 155, 57-79, 2023 | 14 | 2023 |
| Advances in nanoparticle mediated targeting of RNA binding protein for cancer R Kashikar, AK Kotha, S Shah, P Famta, SB Singh, S Srivastava, ... Advanced Drug Delivery Reviews 185, 114257, 2022 | 13 | 2022 |
| Quality by design fostered fabrication of cabazitaxel loaded pH-responsive Improved nanotherapeutics against prostate cancer S Shah, P Famta, R Kumar, A Sharma, G Vambhurkar, G Pandey, G Singh, ... Colloids and Surfaces B: Biointerfaces 234, 113732, 2024 | 10 | 2024 |
